Ardelyx, Inc. (ARDX)
6.55
-0.08
(-1.21%)
USD |
NASDAQ |
Feb 27, 16:00
6.55
0.00 (0.00%)
After-Hours: 20:00
Ardelyx Research and Development Expense (Quarterly) : 21.94M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 280.00M |
| MannKind Corp. | 14.06M |
| Vertex Pharmaceuticals, Inc. | 973.70M |
| PTC Therapeutics, Inc. | 133.13M |
| Fate Therapeutics, Inc. | 22.61M |